Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and is increasing in incidence. Local ablative therapy plays a leading role in HCC treatment. Radiofrequency (RFA) is one of the first-line therapies for early local ablation. Other local ablation techniques...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kunpeng, Wang, Cong, Jiang, Hao, Zhang, Yaqiong, Lin, Weidong, Mo, Jinggang, Jin, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714655/
https://www.ncbi.nlm.nih.gov/pubmed/34975896
http://dx.doi.org/10.3389/fimmu.2021.792781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714655/
https://www.ncbi.nlm.nih.gov/pubmed/34975896
http://dx.doi.org/10.3389/fimmu.2021.792781

Ejemplares similares